Congo vs Eswatini: Incidence of tuberculosis
Incidence of tuberculosis over time
- Congo
- Eswatini
How they compare
Eswatini currently reports 319 per 100,000 people against 302 per 100,000 people in Congo, a difference of 17 per 100,000 people.
That makes Eswatini's figure about 1.1 times Congo's.
Across all 25 years both countries report, Eswatini has been ahead every year.
Congo ranks 21st and Eswatini ranks 20th of 208 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 496.3 per 100,000 people | 1,298 per 100,000 people | 801.8 per 100,000 people | Eswatini |
| 2010s | 361.1 per 100,000 people | 837.6 per 100,000 people | 476.5 per 100,000 people | Eswatini |
| 2020s | 298.8 per 100,000 people | 330 per 100,000 people | 31.2 per 100,000 people | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Congo or Eswatini?
- Eswatini, at 319 per 100,000 people against 302 per 100,000 people in Congo as of 2024.
- What is the difference in incidence of tuberculosis between Congo and Eswatini?
- 17 per 100,000 people, with Eswatini ahead.
- How many years of comparable data are there for Congo and Eswatini?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Eswatini rank globally for incidence of tuberculosis?
- Congo ranks 21st and Eswatini ranks 20th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.